Alere

Epocal develops and provides a point of care blood diagnostic systems for healthcare enterprises. The company has produced epoc, a wireless bedside blood testing solution that provides lab results directly to a hand-held mobile computer. Epocal offers its products for hospitals, physicians’ offices, and patients’ homes. The company was founded in 2001 and is based in Ottawa, Canada.

eScreen, Inc. is a company that develops, manufactures, and markets a range of employment screening products, focusing primarily on pre-employment drug testing and related services. Founded in 1998 and based in Overland Park, Kansas, eScreen offers various innovative solutions designed to streamline the hiring process for employers, donors, and clinics. Its product lineup includes the eScreen instrumented point-of-collection testing device, eScreen123 software for occupational health providers, and MyeScreen.com for online program management and result reporting. Additionally, the company provides the eCup, a self-contained testing device that simplifies sample handling, and the eReader, which facilitates paperless testing. Other offerings include the mCup and mCheck devices for manual urine drug testing. eScreen also delivers web-based services that offer real-time drug test data to enhance efficiency in workforce management.

Arriva Medical specializes in supplying diabetic testing products, focusing on enhancing the diabetes management experience for patients. The company offers a range of testing supplies, including advanced talking meters and element meters designed to facilitate accurate monitoring of blood glucose levels. By providing these essential tools, Arriva Medical aims to support individuals with diabetes in managing their condition effectively and improving their overall health outcomes.

RMD Networks is a company that specializes in appointment scheduling services designed to facilitate interactions between healthcare providers and patients. Its platform allows users to efficiently schedule appointments, request medication refills, obtain referrals, and manage personal health records. Additionally, RMD Networks addresses insurance and billing issues while enabling seamless communication between patients and their care providers. By streamlining these processes, the company enhances the overall patient experience and fosters better healthcare management.

Free & Clear, Inc. specializes in providing phone-based tobacco treatment services to employers, health plans, and government agencies. The company offers comprehensive tobacco cessation programs, including the Quit For Life Program, which is designed to help employees and members of private organizations quit smoking and using smokeless tobacco through clinically proven methods. In addition, Free & Clear addresses broader health risks associated with chronic diseases by offering the Mind & Body Program, a behavior change solution aimed at helping individuals achieve and maintain a healthy weight. Through these services, Free & Clear aims to promote healthier lifestyles and reduce the impact of tobacco use on public health.

Redwood Toxicology Laboratories provides extensive drug and alcohol monitoring as well as laboratory facilities at a low cost.

Biosite Incorporated provides diagnostic products and antibody development technologies for sever diseases. It provides seversl products such as Triage drug of abuse panel, a point-of-care diagnostic test for detecting overdosed prescription and illicit drugs; Triage TOX Drug Screen, a fluorescence immunoassay to detect abused drugs; Triage cardiac panel, a diagnosis aid for heart attack; and Triage BNP test, a diagnosis and assessment aid for the heart failure; and other products. It also provides Triage D-dimer test, an immunoassay for use as an aid in the assessment and evaluation of patients having disseminated intravascular coagulation or thromboembolic events. Furthermore, it offers medical education, technical service and support, and consulting services. Biosite Incorporated distributes its products through distributors in the United States and internationally. It was established in 1988 and is based in San Diego, California with sales offices in Switzerland, the Asia Pacific, the Netherlands, France, Germany, Italy, Spain, and the United Kingdom. Currently it operates as a subsidiary of Alere Inc.

Quality Assured Services is a privately held provider of diagnostic home tests and services.

Cholestech, established in 1988 and headquartered in San Diego, California, specializes in developing point-of-care diagnostic solutions for chronic diseases. The company is renowned for its flagship product, Cholestech LDX®, which measures cholesterol, glucose, liver enzymes, and C-reactive protein to identify high-risk heart disease patients. Additionally, Cholestech offers the GDX system for A1C testing. In 2007, Alere (formerly Inverness Medical) acquired Cholestech for $326.3 million.

Instant Technologies is a prominent manufacturer of on-site rapid test devices, specializing in drug and alcohol testing, women's health, and clinical diagnostics. The company focuses on providing reliable and efficient testing solutions to meet the needs of various sectors, including healthcare and workplace environments. By developing innovative testing technologies, Instant Technologies aims to enhance the accuracy and speed of diagnostic processes, contributing to improved health outcomes and safety standards.

CLONDIAG chip technologies is a company which has developed a multiplexing technology for nucleic acid and immunoassay based diagnostics.

Ischemia Technologies is a Denver-based company that specializes in the development and manufacturing of diagnostic tests for cardiovascular and acute care medicine. The company focuses on creating in-vitro diagnostic products specifically designed to detect cardiac ischemia, a condition characterized by insufficient blood supply to the heart due to obstruction of a coronary artery. By providing advanced diagnostic devices, Ischemia Technologies enables medical professionals to address critical clinical situations that demand immediate and accurate diagnosis, thereby improving patient outcomes in acute care settings.